These findings imply that the molecular routes relevant to NF-κB, PLD, and FcεRI, as well as NKC-mediated cytotoxicity (ultimately leading to cell apoptosis), are instrumental in the therapeutic mechanism of QJHTD against COPD. This evidence concerns the gene GPLD1 and chronic obstructive pulmonary disease.